Sierra Capital LLC Abb Vie Inc. Transaction History

Sierra Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $412 - $524	-3 Reduced 0.14%	2,136 $327,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $88,737 - $112,278	826 Added 62.91%	2,139 $290,000
Q1 2021 May 28, 2021	BUY	$102.3 - $112.62 $134,319 - $147,870	1,313 New	1,313 $142,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.